Lipocine Inc. (LPCN)
NASDAQ: LPCN · Real-Time Price · USD
5.35
-0.68 (-11.28%)
Nov 7, 2024, 11:24 AM EST - Market open
Lipocine Income Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | 2018 - 2014 |
|---|---|---|---|---|---|---|---|
Period Ending | Jun '24 Jun 30, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 | 2018 - 2014 |
| Revenue | 4.8 | -2.85 | 0.5 | 16.14 | - | 0.16 | Upgrade
|
| Revenue Growth (YoY) | 8630.55% | - | -96.90% | - | - | -61.45% | Upgrade
|
| Gross Profit | 4.8 | -2.85 | 0.5 | 16.14 | - | 0.16 | Upgrade
|
| Selling, General & Admin | 5.26 | 4.9 | 4.06 | 5.33 | 8.25 | 5.6 | Upgrade
|
| Research & Development | 9.25 | 10.18 | 8.56 | 7.67 | 9.75 | 7.47 | Upgrade
|
| Operating Expenses | 14.51 | 15.08 | 12.62 | 13 | 18 | 13.07 | Upgrade
|
| Operating Income | -9.71 | -17.93 | -12.12 | 3.15 | -18 | -12.9 | Upgrade
|
| Interest Expense | - | - | -0.03 | -0.2 | -0.39 | -0.77 | Upgrade
|
| Interest & Investment Income | 1.26 | 1.37 | 0.57 | 0.07 | 0.08 | 0.42 | Upgrade
|
| Other Non Operating Income (Expenses) | -0.04 | 0.21 | 0.57 | 0.36 | -2.89 | 0.24 | Upgrade
|
| EBT Excluding Unusual Items | -8.49 | -16.35 | -11.01 | 3.37 | -21.2 | -13.01 | Upgrade
|
| Legal Settlements | - | - | 0.25 | -4 | - | - | Upgrade
|
| Other Unusual Items | - | - | - | - | 0.23 | - | Upgrade
|
| Pretax Income | -8.49 | -16.35 | -10.76 | -0.63 | -20.96 | -13.01 | Upgrade
|
| Income Tax Expense | 0 | 0 | 0 | 0 | 0 | 0 | Upgrade
|
| Net Income | -8.49 | -16.35 | -10.76 | -0.63 | -20.96 | -13.01 | Upgrade
|
| Preferred Dividends & Other Adjustments | - | 0 | - | - | - | - | Upgrade
|
| Net Income to Common | -8.49 | -16.35 | -10.76 | -0.63 | -20.96 | -13.01 | Upgrade
|
| Shares Outstanding (Basic) | 5 | 5 | 5 | 5 | 3 | 2 | Upgrade
|
| Shares Outstanding (Diluted) | 5 | 5 | 5 | 5 | 3 | 2 | Upgrade
|
| Shares Change (YoY) | 1.57% | 0.26% | 1.98% | 57.35% | 115.16% | 21.22% | Upgrade
|
| EPS (Basic) | -1.60 | -3.10 | -2.06 | -0.12 | -6.40 | -8.54 | Upgrade
|
| EPS (Diluted) | -1.61 | -3.14 | -2.15 | -0.19 | -6.46 | -8.54 | Upgrade
|
| Free Cash Flow | -4.73 | -11.88 | -12.1 | -4.42 | -15.3 | -11.67 | Upgrade
|
| Free Cash Flow Per Share | -0.89 | -2.25 | -2.30 | -0.86 | -4.67 | -7.66 | Upgrade
|
| Gross Margin | 100.00% | - | 100.00% | 100.00% | - | 100.00% | Upgrade
|
| Operating Margin | -202.18% | - | -2423.88% | 19.49% | - | -7818.83% | Upgrade
|
| Profit Margin | -176.80% | - | -2151.73% | -3.93% | - | -7883.72% | Upgrade
|
| Free Cash Flow Margin | -98.48% | - | -2420.53% | -27.38% | - | -7070.86% | Upgrade
|
| EBITDA | -9.67 | -17.9 | -12.11 | 3.15 | -17.99 | -12.88 | Upgrade
|
| EBITDA Margin | -201.50% | - | - | 19.49% | - | - | Upgrade
|
| D&A For EBITDA | 0.03 | 0.03 | 0.01 | 0 | 0 | 0.02 | Upgrade
|
| EBIT | -9.71 | -17.93 | -12.12 | 3.15 | -18 | -12.9 | Upgrade
|
| EBIT Margin | -202.18% | - | - | 19.49% | - | - | Upgrade
|
| Revenue as Reported | 4.8 | -2.85 | 0.5 | - | - | 0.16 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.